16 June 2025
Our new strategy to 2030, which launched on Monday (16 June), sets out how the partnership will pioneer better health for all, together, and make a tangible difference to our communities.
Basirah tells us about her work on Neuro-rehabilitation wards preparing patients and their families for 'new reality'.
KHP Diabetes, Endocrinology and Obesity recently conducted a health needs assessment to better understand the needs of people living with both a severe mental illness and type 2 diabetes.
We hear about the findings from the international BETTER-B randomised trial. The aim of the project was to test the effectiveness of mirtazapine (a drug repurposed for severe breathlessness) in patients with advanced respiratory diseases.
Multiple myeloma, also known as myeloma, is a type of bone marrow cancer.
Prof Graham Lord, MA MB BChir PhD FRCP FRSB FMedSci, NIHR Senior Investigator Emeritus, joins King's Health Partners as its new Executive Director.
Mr Karagama – consultant Ear, Nose and Throat (ENT) surgeon and laryngologist – shares how he is supporting the the development of surgical innovations with the aim transform his practice and improve quality of life for patients.
As newly elected president for the American Society for Bone and Mineral Research, Prof Emma Duncan will champion the KHP ethos of clinical academic collaboration, to help people living with bone-related disorders across the globe.
The Institute represents an exciting opportunity to combine resources and research strengths across King's Health Partners.
"Blood clots are the leading cause of preventable deaths in hospitals and there is still so much we don’t understand about them. This means that research in this area has the potential to save many lives."
Learning Hub
Sign up to our newsletter
